Observia
Vincent Galand has a diverse work experience in the healthcare and business sectors. Vincent is currently working at Observia as the Head of BD & Partnerships France, where they lead initiatives in advanced digital patient engagement solutions. Prior to this, they worked as a Lecturer and Course creator at ESCP Business School, focusing on deeptech entrepreneurship. Vincent also has experience as an investor at Alzprotect SAS and as a Pepite Mentor/Coach at PSL-Pépite, where they promote and develops the skills of young entrepreneurs. Vincent Galand is also a founding member of the Coalition Next, a public-private partnership in healthcare, and a partner at d2a - Digital to Accelerate. Vincent has previous experience as a founding partner at Digital Pharma Lab, an entrepreneur at Coalition Next, a member of the Expert Network Division at Ivy Exec, and a lecturer at emlyon business school. Additionally, they served as an Operations Executive at Embleema, where they played a key role in fundraising efforts and M&A brokerage.
Vincent Galand's education history includes a Bachelor and Master of Science and Technology degree from Université Grenoble Alpes, a Master of Science degree in Molecular Medicine from Cranfield University, a Master's degree in Innovation Management from Grenoble Ecole de Management, a B.Sc thesis (hons) in Biochemistry and Cancer Biology from UC San Diego, and an M.Sc thesis (hons) in Stem Cells and Regenerative Medicine from Harvard University. Vincent also obtained additional certifications, including a White Belt Lean Six-Sigma from Safran, International Organizations Management from Université de Genève, and Veille stratégique et Intelligence économique from ADIT.
This person is not in any offices
Observia
Since 2011, we have been a passionate pioneering health tech company committed to driving the healthcare (r)evolution and improving patients’ lives. We work with healthcare stakeholders that aim to create value at every step of the patient journey: industrial companies, healthcare facilities, healthcare professionals, and patient organizations. As a European reference, we help companies to develop personalized, intelligent patient engagement and support solutions, and to define and implement patient strategies. We have created a new generation of evidence-based tools to support efficient patient behavioral change and improve the user experience. d.tells™, our smart engine for personalizing patient solutions, is powered by SPUR™, our behavioral diagnostic tool, and OPC™, our digital cloud platform that supports client’s developments. Our products are anchored in the behavioral sciences and driven by artificial intelligence, two critical pillars that promote effective personalization. These tools successfully help patients to overcome behavioral challenges, such as treatment non-adherence, and deliver clinically measurable results. Observia has been created in 2011 by three founders. After 3 years in Paris Biotech Santé incubator in Cochin hospital, Observia settled in Paris and opened a subsidiary in Shanghai in 2018. In 2021, the company employs more than 50 people and does 60% of its turnover internationally.